WebAlnylam a une note de 4,1 sur 5 concernant la diversité et l'inclusion, d'après 61 évaluations anonymes de la communauté. La note moyenne sur la diversité et l'inclusion laissée par la communauté d'employés travaillant chez Alnylam a baissé de 6 % ces 12 derniers mois. Répartition des évaluations sur la diversité et l'inclusion.
Akshara Thadakamalla على LinkedIn: I am excited to announce that …
WebJul 1, 2024 · Shares of Alnylam (ALNY-0.85%) recently dipped after Intellia (NTLA 0.37%) stole the spotlight with trial results for a revolutionary new gene therapy that could … Web1 day ago · The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash ... kilic herne
Alnylam: diversidade, equidade e inclusão Glassdoor
WebApr 12, 2024 · 19.60. USD. -0.36%. 22:29. Vente d'initié : Syndax Pharmaceuticals. MT. 30/03. Syndax Pharmaceuticals, Inc. annonce la nomination de Neil Gallagher au poste de président, responsable de la ... WebAlnylam Pharmaceuticals Message board - Online Community of active, educated investors researching and discussing Alnylam Pharmaceuticals Stocks. WebApr 12, 2024 · Alnylam Drugs has finished enrolment in its Stage II preliminary with ALN-TTR02, a RNAi remedial focusing on the Transthyretin Pipeline Drugs Market quality for the treatment of TTR-intervened amyloidosis (ATTR).. ALN-TTR02 is accounted for to have accomplished around 93% knockdown of TTR, the illness causing protein in ATTR, in the … kilic orthopäde